ClinicalTrials.gg
Status unknownNCT02756156Updated Apr 29, 2016

Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

An observational study in Humerus Fracture, sponsored by Kahramanmaras Sutcu Imam University. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-04-29.

Sponsored by Kahramanmaras Sutcu Imam University · Observational

The sponsor has not verified this record recently (last verified Mar 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

Combining interscalene block with infraclavicular block for humerus surgery provides a unique surgical anaesthesia and postoperative analgesia.

Read the detailed description

Interscalene block provides effective surgical anaesthesia for shoulder and proximal arm surgery. However, sometimes it can be inadequate for distal arm surgery. Combining infraclavicular block with interscalene block may provide a successful surgical anaesthesia for humerus surgery.

02

Conditions studied

  • Humerus Fracture

Browse trials for

Keywords

  • interscalene
  • infraclavicular
  • humerus surgery
03

In context

Humeral Fractures

178 studies on the registry are indexed under Humeral Fractures; 25 are open to participants now.

This study's planned enrollment of 30 is below the median of 89 across 70 observational studies indexed under Humeral Fractures.

Browse Humeral Fractures studies →

Lead sponsor

Kahramanmaras Sutcu Imam University is the lead sponsor of 195 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients undergoing humerus surgery.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients accepting peripheral nerve block technique for humerus surgery
  • Unilateral orthopedic humerus surgery
  • 18 years of age or older

Exclusion criteria

Exclusion Criteria:

  • Patients refused peripheral nerve block
  • Non-cooperate patients
  • Neuropathy of any etiology in the affected extremity
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
30 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Success rate of block

    A complete sensory loss in distribution of the radial, median, ulnar, musculocutaneous and medial cutaneous nerves of the arm

    Time frame: 10 min.- 20 min.

Secondary outcomes

  1. Technique duration

    Time frame: 5 min.

  2. Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

    Time frame: 24 hours

  3. Complication rate

    Time frame: 24 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2016, a primary completion of Aug 2016 and a completion of Aug 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 15, 2016
First posted
Apr 29, 2016
Start
Apr 2016
Primary completionEst.
Aug 2016
CompletionEst.
Aug 2016
Last update
Apr 29, 2016
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 29, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02756156
Responsible party
Bora Bilal (Assist prof, Kahramanmaras Sutcu Imam University) — Principal investigator
First posted
Apr 29, 2016
Start date
Apr 2016
Primary completion
Aug 2016 (estimated)
Completion
Aug 2016 (estimated)
Last update
Apr 29, 2016

Study contacts

Bora Bilal, Asist. Prof.
Contact
bilalbora@yahoo.com
+903442803245

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion